Primary Brain Tumor
32
8
9
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
2 terminated out of 32 trials
88.9%
+2.4% vs benchmark
9%
3 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (32)
Non-invasive Glioma Characterization Through Molecular Imaging
A Study of Avutometinib for People With Solid Tumor Cancers
Assessment of Eloquent Function in Brain Tumor Patients
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Neurocognitive Function After Proton Therapy in Children and Adolescents
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors
Impact of the Development of Pediatric Palliative Care
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
CBT for Insomnia in Primary Brain Tumor Patients
The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers
Cognitive Function After Radiation Therapy for Brain Tumours